Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Glycemic control in the critically ill: Less is more

Ghaith Alhatemi, MD, Haider Aldiwani, MD, Rafal Alhatemi, MD, Marwah Hussein, MD, Suzan Mahdai, MD and Berhane Seyoum, MD
Cleveland Clinic Journal of Medicine April 2022, 89 (4) 191-199; DOI: https://doi.org/10.3949/ccjm.89a.20171
Ghaith Alhatemi
Department of Internal Medicine, Saint Mary Mercy Hospital, Livonia, MI; Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Haider Aldiwani
Department of Internal Medicine, Palomar Medical Center, Escondido, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafal Alhatemi
Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marwah Hussein
Department of Internal Medicine, Division of Endocrinology, Wayne State University/Detroit Medical Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzan Mahdai
Department of Internal Medicine, Scripps Mercy Hospital Chula Vista, San Diego, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berhane Seyoum
Department of Internal Medicine, Division of Endocrinology, Wayne State University/Detroit Medical Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Recommendations for blood glucose targets for insulin therapy

    Professional societyYearRecommendations
    American Diabetes Association702021Insulin therapy should be initiated for treatment of persistent hyperglycemia at a threshold 180 mg/dL.
    Once insulin therapy is started, a target blood glucose range of 140–180 mg/dL is recommended for most critically ill patients.
    More stringent goals, such as 110–140 mg/dL, may be appropriate for selected patients if they can be achieved without significant hypoglycemia.
    American College of Physicians712014Best practice advice 1: Clinicians should target a blood glucose level of 140–200 mg/dL if insulin therapy is used in surgical or medical patients in the intensive care unit.
    Best practice advice 2: Clinicians should avoid targets < 140 mg/dL because harms are likely to increase with lower glood glucose targets.
    Society of Critical Care Medicine722012A blood glucose level ≥ 150 mg/dL should trigger initiation of insulin therapy, titrated to keep the level < 150 mg/dL for most adult intensive care unit patients, and to maintain blood glucose values absolutely < 180 mg/dL using a protocol that achieves a low rate of hypoglycemia (blood glucose ≤ 70 mg/dL) despite limited impact on patient mortality.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 89 (4)
Cleveland Clinic Journal of Medicine
Vol. 89, Issue 4
1 Apr 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Glycemic control in the critically ill: Less is more
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Glycemic control in the critically ill: Less is more
Ghaith Alhatemi, Haider Aldiwani, Rafal Alhatemi, Marwah Hussein, Suzan Mahdai, Berhane Seyoum
Cleveland Clinic Journal of Medicine Apr 2022, 89 (4) 191-199; DOI: 10.3949/ccjm.89a.20171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Glycemic control in the critically ill: Less is more
Ghaith Alhatemi, Haider Aldiwani, Rafal Alhatemi, Marwah Hussein, Suzan Mahdai, Berhane Seyoum
Cleveland Clinic Journal of Medicine Apr 2022, 89 (4) 191-199; DOI: 10.3949/ccjm.89a.20171
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • METRICS OF GLYCEMIC CONTROL
    • HYPOGLYCEMIA: A COMPLICATING FACTOR
    • GLYCEMIC TARGETS IN CLINICAL STUDIES
    • EXPLAINING DISCREPANCIES IN STUDY RESULTS
    • WHAT DO MEDICAL SOCIETIES RECOMMEND?
    • TAKE-HOME MESSAGE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Glycemic targets in the ICU: A look back, and ahead
  • PubMed
  • Google Scholar

Cited By...

  • Towards net zero: critical care
  • Glycemic targets in the ICU: A look back, and ahead
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Diabetes
  • Drug Therapy
  • Emergency Medicine
  • Endocrinology
  • Hospital Medicine
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire